HINDUSTAN UNILEVER LTD. (HINDUNILVR)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2FY27 underlying sales growth (USG) 15%, underlying volume growth (UVG) 7%
- EBITDA margin 22.6%, EBITDA Rs. 4,089 Cr (+8% y-y), PAT before exceptional items Rs. 2,795 Cr (+9% y-y)
- Home Care USG 22%, Beauty & Wellbeing USG 16%, Personal Care and Foods USG 9% each
- Medium-term EBITDA margin guidance maintained at 22-24%
- Strategy focuses on portfolio transformation, premiumisation, channel expansion, and AI-driven efficiencies
- Rural demand growing sequentially, broad-based growth across categories and channels
- Pricing strategy passes absolute cost increases fully with calibrated price hikes
- Multiple analyst queries on margin trajectory and volume outlook; management confident on volume-led growth and margin recovery
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HINDUNILVR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HINDUNILVR to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on HINDUSTAN UNILEVER LTD.
Important.
The summary above is generated automatically from HINDUSTAN UNILEVER LTD.'s own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.